Results from This Site: 11 - 20 of 57 total results for Pfizer
  • Pfizer said it is considering the sale or spin-off of its substantial consumer healthcare division. CEO Ian Read said that while the OTC business has a "strong connection" to Pfizer's main pharmaceuticals
  • Inflectra, co-marketed by Pfizer and Celltrion. Confectioner Ferrero is dipping its toe into the catering industry with the launch of the first ever Nutella Cafe, not in its home country of Italy but
  • Pfizer once again dominated the pharmaceutical sector in 2016 in direct-to-consumer advertising. According to figures from Nielsen it spent a whopping $1.19bn to market its drugs to US consumers last
  • Wellness, moving across from WPP's Team Pfizer vertical agency. In keeping with a philosophy of "If You Can't Beat 'Em, Buy 'Em", WPP has acquired US-based multicultural agency Zubi Advertising Services,
  • and Abbvie over 4%. Pfizer, Amgen, Eli Lilly and Gilead fell more than 2% each. A few days later Trump was back onto the automobile sector again, starting a row with Germany with typically uninformed
  • On the creative side, Pfizer quietly rejigged its roster, shifting Nexium, one of its biggest OTC spenders, from Leo Burnett to Grey, and Centrum vitamins to indie BurnsGroup. Asahi Breweries appointed
  • In a new move to simplify its structure, Pfizer is said to be considering the sale or spin-off of its consumer healthcare division, with brands including Advil, Centrum and Chapstick. The story was first
  • Pfizer is still shopping. A few days after agreeing to acquire US oncology drugmaker Medivation, it snapped up AstraZeneca's international antibiotics portfolio for up to $1.6bn, to be paid over several
  • Pfizer trumped rival Sanofi by clinching a deal to acquire US drug developer Medivation, makers of the blockbuster prostate cancer drug Xtandi (co-marketed by Japanese company Astellas). Medivation was
  • as well as to two other suitors, Pfizer and Celgene. Separately, Sanofi agreed terms to transfer ownership of its animal health division Merial to German counterpart Boehringer Ingelheim, in return for

All rights reserved © Mind Advertising Ltd 1998-2019